Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page
- Check2 days agoChange DetectedThe history list now shows a new revision entry v3.5.5, with the previous v3.5.4 removed from the visible history. This change represents an update to the page's revision metadata rather than substantive changes to the study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe history now shows a new Revision: v3.5.4 entry, replacing the previous Revision: v3.5.3. This represents a system version update to the page's history interface and does not alter the underlying study content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe study record version was updated to v3.5.3, replacing the previous v3.5.2.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdated the site revision/version indicator from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the history log.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision entry, v3.4.3, was added and the previous revision entry, v3.4.2, was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.